Change in HER2 status after neoadjuvant chemotherapy (NAC) with trastuzumab and pertuzumab (HP) in patients with HER2-positive early-stage breast cancer Meeting Abstract

  


Authors: Ferraro, E.; Razavi, P.; Chandarlapaty, S.; Modi, S.; Wen, H. Y.; Brogi, E.; Norton, L.; Robson, M. E.; Dang, C. T.
Abstract Title: Change in HER2 status after neoadjuvant chemotherapy (NAC) with trastuzumab and pertuzumab (HP) in patients with HER2-positive early-stage breast cancer
Meeting Title: 2021 ASCO Annual Meeting
Journal Title: Journal of Clinical Oncology
Volume: 39
Issue: 15 Suppl.
Meeting Dates: 2021 Jun 4-8
Meeting Location: Virtual
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2021-05-20
Language: English
ACCESSION: WOS:000708120300105
DOI: 10.1200/JCO.2021.39.15_suppl.e12614
PROVIDER: wos
Notes: Meeting Abstract: e12614 -- Source: Wos
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Larry Norton
    758 Norton
  2. Mark E Robson
    676 Robson
  3. Chau Dang
    271 Dang
  4. Hannah Yong Wen
    301 Wen
  5. Shanu Modi
    265 Modi
  6. Sarat Chandarlapaty
    279 Chandarlapaty
  7. Edi Brogi
    515 Brogi
  8. Pedram Razavi
    173 Razavi
  9. Emanuela Ferraro
    31 Ferraro
Related MSK Work